Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel bipropoxyphenyl-methylsulfonylamide compound for adjusting activity of estrogen-related receptor and medical purpose thereof

A compound, estrogen technology, applied in organic chemistry, amide active ingredient, drug combination, etc.

Inactive Publication Date: 2017-04-19
QILU UNIV OF TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These studies suggest that modulators targeting ERRα have the potential to serve as clinically effective antitumor agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel bipropoxyphenyl-methylsulfonylamide compound for adjusting activity of estrogen-related receptor and medical purpose thereof
  • Novel bipropoxyphenyl-methylsulfonylamide compound for adjusting activity of estrogen-related receptor and medical purpose thereof
  • Novel bipropoxyphenyl-methylsulfonylamide compound for adjusting activity of estrogen-related receptor and medical purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0025] Example 2 The detection technology of time-resolved fluorescence resonance energy transfer (Time-Resolved Fluoresen-ce Resonance Energy Transfer assay, TR-FRET assay) was used to test the competitive binding activity of the compound of formula I of the present invention to ERRα at the molecular level

[0026]This example illustrates that the compounds involved in the present invention can effectively inhibit the combination of ERRα and PGC1α, indicating that the compounds involved in the present invention competitively bind to ERRα (molecular level). TR-FRET is a technique familiar to those skilled in the art. FRET (Fluorescence Resonance Energy Transfer), that is, fluorescence resonance energy transfer, is based on the energy transfer of two fluorophores (donor and acceptor), when the two fluorophores are close to each other. Interactions between biomacromolecules can be measured with fluorescent labels and energy transfer between the two. When the two groups are clos...

Embodiment 3

[0030] Example 3 Using CCK-8 Cell Proliferation Assay to Determine the Proliferation Inhibitory Effects of Compounds on Various Tumor Cell Lines

[0031] This example illustrates that the compounds involved in the present invention can effectively inhibit the proliferation of various tumor cell lines, indicating that the compounds involved in the present invention exhibit effective anti-tumor activity in vitro. The CCK-8 cell proliferation assay is a technique familiar to those skilled in the art.

[0032] (1) Tumor cell culture and seeding in 96-well cell culture plate: Take out the tumor cells in the logarithmic growth phase in good condition, observe the cell morphology, if the cells have been 80% confluent, start passage. Wash and discard the old culture medium in the petri dish, wash with sterile 1mL PBS for 3-5 times, add 1mL of warmed trypsin, shake the dish horizontally to make the trypsin evenly distributed and fully digested. Put the cells in the incubator for 1-2 m...

Embodiment 4

[0037] Example 4 Using Transwell tumor cell migration assay to determine the effect of compounds on the migration function of breast cancer cell MDA-MB-231

[0038] This example illustrates that the compounds involved in the present invention can effectively inhibit the migration of breast cancer cells MDA-MB-231, indicating that the compounds involved in the present invention exhibit effective anti-migration activity of breast cancer cells in vitro. Transwell tumor cell migration assay is a technique familiar to those skilled in the art.

[0039] (1) Preparation of Transwell chamber: Matrigel 1:8 (50mg / L) dilution was used to coat the upper chamber surface of the bottom membrane of the Transwell chamber to coat the basement membrane, and air-dried at 4°C. After air-drying, hydrate the basement membrane, suck out the residual liquid in the culture plate, add 50uL serum-free DMEM culture solution containing 10g / L BSA to each well, and incubate in a 37°C incubator for 30min.

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel bipropoxyphenyl-methylsulfonylamide compound (as shown in the formula I) for adjusting activity of an estrogen-related receptor and pharmaceutically acceptable salt and application thereof. The compound and the pharmaceutically acceptable salt can be used in preparation of medicines for adjusting activity of the estrogen-related receptor ERR-alpha (Estrogen-related receptor alpha, ERR-alpha or ERRalpha) and preventing and treating malignant tumors such as breast cancer, prostate cancer, stomach cancer, colorectal carcinoma, ovarian cancer, cervical carcinoma, etc.

Description

technical field [0001] The present invention relates to a novel dipoxyphenyl-methanesulfonamide compound and a pharmaceutically acceptable salt thereof as a modulator for regulating estrogen-related receptor alpha (ERR-alpha, ERR-alpha or ERRα) The medicine combination thereof and the application thereof in preparing medicines for preventing and / or treating tumors such as breast cancer, prostate cancer, gastric cancer, colon cancer, ovarian cancer, cervical cancer or endometrial cancer. Background technique [0002] ERRα was cloned and identified by Giguere et al. in 1988. As an orphan nuclear receptor (Orphan nuclear receptor), the endogenous ligand of ERRα has not been discovered. ERRα is widely expressed in the body and can be detected from myocardium, digestive tract, brain, skeletal muscle, brown fat, breast cancer, ovarian cancer and other malignant tumors. ERRα has high homology with estrogen receptor α (ERα): DNA binding domain (DNA binding domain, DBD) amino acid ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C311/08A61K31/18A61P35/00
CPCA61K31/18C07C311/08
Inventor 杜永丽李群益凌浩张留弟
Owner QILU UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com